Literature DB >> 18407222

Growth in growth hormone insensitivity.

A L Rosenbloom1, J Guevara-Aguirre, R G Rosenfeld, B H Pollock.   

Abstract

Primary GH insensitivity due to GH receptor deficiency (GHRD) provides a model for studying the discrete effects of severe IGF-I deficiency on growth and body composition. Growth failure in utero is doubtful, but postpartum growth proceeds at rates that result in adult statures 4-12 standard deviations (SDs) below the normal mean. Wide variability in statural effect, even in a genetically homogeneous population, is partly explained by correlation of SD score with biochemical measures of GH effect (IGF-I, IGF-II, and IGFBP-3). Growth and changes in body composition (decreased fat/lean) in patients with GHRD in response to exogenous IGF-I indicate that direct local effects of GH are not necessary for these responses.

Entities:  

Year:  1994        PMID: 18407222     DOI: 10.1016/1043-2760(94)p3205-l

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  5 in total

Review 1.  Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone.

Authors:  N Mauras; M W Haymond
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 2.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

Review 3.  Physiology and disorders of the growth hormone receptor (GHR) and GH-GHR signal transduction.

Authors:  A L Rosenbloom
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

Review 4.  Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.

Authors:  Jaime Guevara-Aguirre; Camila Bautista; Carlos Torres; Gabriela Peña; Carolina Guevara; Cristina Palacios; Alexandra Guevara; Antonio W D Gavilanes
Journal:  Rev Endocr Metab Disord       Date:  2020-10-12       Impact factor: 6.514

Review 5.  Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma.

Authors:  Reham Abdel-Wahab; Samir Shehata; Manal M Hassan; Mouhammed A Habra; Ghazaleh Eskandari; Peggy T Tinkey; Jennifer Mitchell; Ju-Seog Lee; Hesham M Amin; Ahmed O Kaseb
Journal:  J Hepatocell Carcinoma       Date:  2015-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.